Journal
FERTILITY AND STERILITY
Volume 73, Issue 3, Pages 516-521Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0015-0282(99)00553-1
Keywords
pharmacokinetics; bioavailability; Crinone; vaginal progesterone; micronized progesterone; progesterone gel; progesterone capsule; Prometrium
Categories
Ask authors/readers for more resources
Objective: Compare the pharmacokinetics of vaginal progesterone gel (Crinone 8%, 90 mg) with that of oral progesterone (Prometrium, 100 mg). Design: Open-label, randomized, parallel-group protocol. Setting: Outpatient clinic. Patient(s): Twelve healthy postmenopausal women. Intervention(s): Six subjects each were randomized to receive progesterone, which was administered either as 90 mg of progesterone gel (Crinone 8%) given vaginally or 100 mg progesterone in a capsule (Prometrium) given orally. Main Outcome Measurement(s): Serum progesterone levels were measured by both radioimmunoassay (RIA) and liquid chromatography-mass spectrometry (LC-MS). Conclusion(s): Crinone (progesterone gel) given vaginally results in greater bioavailability with less relative variability than oral progesterone, thus providing more reliable delivery of progesterone, compared with oral progesterone. Measuring circulating progesterone with use of direct RIA is not appropriate after oral progesterone administration. (C) 2000 by American Society for Reproductive Medicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available